Benefits
Blood pressure with regular black tea drinking
Two meta-analyses of randomized trials found that drinking black tea regularly lowered blood pressure slightly: about 1 to 2 mmHg systolic and 0.6 to 1.3 mmHg diastolic versus control drinks. These are small shifts in a risk marker, not proof of fewer heart attacks or strokes, and most trials tested the drink rather than capsules. One meta-analysis was funded by a company that sold tea.
Endothelial function and blood vessel dilation
Flow-mediated dilation measures how well an artery widens. A meta-analysis of 9 placebo-controlled studies, mostly of black tea, found 2 to 3 cups a day raised it by 2.6 percentage points, and a crossover in 19 men showed a dose-response. Results were not uniform: a 6-month trial of 3 cups a day found no change. The meta-analysis authors worked for a company that sold tea.
Cholesterol and blood lipids
The lipid trials give mixed results. A Cochrane review of a few small trials and a meta-analysis of 10 trials found black tea lowered LDL cholesterol slightly, but a meta-analysis of 15 trials found no significant change in total or HDL cholesterol, and its LDL drop held in only one of two statistical models. Purified theaflavin capsules, with or without catechins, did not lower LDL in 102 adults over 11 weeks.
Blood sugar after a sugary drink
In a small study of 24 adults with normal or prediabetic blood sugar, a single black tea drink lowered the glucose rise after a sugar drink versus placebo, with no change in insulin. Longer studies were less encouraging: 3 cups a day for 6 months did not change fasting glucose, and a green and black tea extract did not improve HbA1c in people with type 2 diabetes.
Body weight and waist measures
In a 6-month trial of 111 regular tea drinkers, 3 cups a day of black tea powder led to slightly less weight gain (0.64 kg) and a smaller waist (1.9 cm) at 3 months compared with a caffeine-matched placebo drink, but neither difference was still significant at 6 months. This is a single trial, so black tea is not an established weight-management tool.
Mechanism of action
Oxidized tea polyphenols
When black tea leaves oxidize, the catechins that dominate green tea are joined into theaflavins and the larger thearubigins, which are the most abundant black tea polyphenols. Thearubigins are a highly mixed group and are much less studied, so it is unclear which compounds drive the effects seen in tea drinkers.
Effects on the blood-vessel lining
In patients with coronary artery disease, black tea improved artery widening that depends on the vessel lining (the endothelium) but not widening triggered by nitroglycerin, and a 200 mg dose of caffeine alone had no acute effect. This points to the tea flavonoids acting on the endothelium itself rather than to caffeine.
Binding iron in the gut
Black tea polyphenols reduce the absorption of non-heme iron (the form in plant foods, fortified foods and most supplements) eaten at the same meal, and the effect grows with the drink's polyphenol content. This is a drawback for people who need iron rather than a benefit.
Clinical trials
Systematic review and meta-analysis of placebo-controlled black tea intervention studies lasting at least 1 week, funded by Unilever, which employed four of the authors (Greyling et al. 2014, PLoS One).
11 studies, 12 intervention arms, 378 adults; about 4 to 5 cups of black tea a day, as leaf tea in 6 studies and dissolved tea extract powder in 5.
Systolic pressure fell by 1.8 mmHg (95% CI 0.7 to 2.8) and diastolic by 1.3 mmHg (95% CI 0.8 to 1.8) versus placebo. Powder studies showed larger systolic drops than leaf-tea studies, and effects were larger at higher starting blood pressure. These were beverage trials, not capsule supplements, and the effect is small.
Meta-analysis of placebo-controlled human intervention studies of tea on brachial artery flow-mediated dilation (FMD), written by Unilever employees (Ras et al. 2011, PLoS One).
9 studies (15 arms) in healthy people and patient groups; 7 studies tested black tea and 3 tested green tea; median 500 mL of tea a day (2 to 3 cups).
Tea raised FMD by 2.6 percentage points (95% CI 1.8 to 3.3) versus placebo, with significant heterogeneity between studies. FMD is a marker of blood-vessel function, not a clinical outcome. All studies tested brewed or dissolved tea drinks.
Randomized, double-blind, controlled crossover of black tea providing 0, 100, 200, 400 and 800 mg tea flavonoids a day, each for 1 week (Grassi et al. 2009, J Hypertens).
19 healthy men.
FMD rose in step with dose, from 7.8% on control to 9.0, 9.1, 9.6 and 10.3% across the four doses, and even the lowest dose differed from control. Office blood pressure also fell (by 2.6 mmHg systolic and 2.2 mmHg diastolic), as did an arterial stiffness index, with no change in the other measures studied. A short beverage study in a small group of healthy men.
Randomized, double-blind, 6-month parallel trial of 3 cups a day of powdered black tea solids versus a flavonoid-free, flavor- and caffeine-matched placebo drink (Bøhn et al. 2014, Food Funct).
111 regular tea-drinking men and women with BMI 20 to 35.
At 3 months the tea group gained less weight (-0.64 kg) and had a smaller waist (-1.88 cm) than placebo, but these differences were no longer significant at 6 months. There were no significant effects on fasting glucose, insulin, blood lipids or endothelial function. The authors note this same trial earlier reported a blood-pressure benefit not explained by caffeine.
Randomized, double-blind, placebo-controlled parallel trial of once-daily capsules of purified black tea theaflavins or theaflavins plus catechins for 11 weeks (Trautwein et al. 2010, Eur J Nutr).
102 adults with mildly to moderately raised cholesterol (67 men, 35 women).
Neither theaflavins alone (77.5 mg/day) nor theaflavins with catechins (75 mg theaflavins, 150 mg catechins, 195 mg other polyphenols) lowered total or LDL cholesterol versus placebo; cholesterol drifted down in the placebo group too. This tested a supplement extract, not brewed tea.
Randomized, double-blind, placebo-controlled crossover of a single black tea drink taken with a sucrose load (Butacnum et al. 2017, Asia Pac J Clin Nutr).
24 adults aged 20 to 60 with normal or prediabetic blood sugar.
Drinks with 110 or 220 mg of black tea polymerized polyphenols lowered the blood glucose area under the curve over the first 60 minutes versus placebo; insulin responses did not differ. A one-off test of a beverage, not evidence of long-term blood sugar control.
Double-blind, placebo-controlled, randomized trial of a combined green and black tea extract at 0, 375 or 750 mg/day for 3 months (Mackenzie et al. 2007, Metabolism).
49 adults (study completers) with type 2 diabetes not using insulin, average age 65; 80% used glucose-lowering medication.
HbA1c, the primary outcome, rose slightly in all arms (+0.4 placebo, +0.3 at 375 mg, +0.5 at 750 mg) with no difference between groups. The authors found no glucose-lowering effect of the extract.